Outcome of Board Meeting
Fredun Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016, has transacted the following:- Opening Bank AccountThe Board approved the matter of opening a Bank Account of the Company for the business activities of the Company.- General Business ReviewGeneral Discussion took place between the Board on the overall Business Activities of the Company. Standalone Financial Results, Auditors Report for March 31, 2016
Fredun Pharmaceuticals Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Standalone Auditors Report for the period ended March 31, 20163. Declaration on No Audit Qualification Board Meeting on June 08, 2016
Fredun Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on June 08, 2016 to consider, approve and allot 8% Redeemable Non Convertible Cumulative Preference shares to the extent of Rs. 2.50 Crores as per the Resolution passed under Section 42,55,62 and other applicable rules under The Companies Act, 2013 by the shareholders of the Company at an Extra Ordinary General Meeting of the Company held on May 30, 2016. EGM on May 30, 2016
Fredun Pharmaceuticals Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company will be held on May 30, 2016. Updates
Fredun Pharmaceuticals Ltd has informed BSE that the Company intend to issue 8% Redeemable Cumulative Preference shares to very small no of Investors to the extent of Rs. 2.50 Crores only. The shares will not be listed with the Exchange. The shares will be issued subject to The Companies Act, 2013 and the Listing Regulations.An Extra Ordinary General Meeting of the Company is scheduled to be held on May 30, 2016 at 11.00 a.m. to pass the necessary Resolutions. Outcome of Board Meeting (EGM on May 30, 2016)
Fredun Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 27, 2016, has approved the matter of Issue of 8% Redeemable Cumulative Preference shares of Rs. 25,000,000/-(Rupees Two Crore Fifty lacks only) subject to the approval of the shareholders of the Company.The 8% Redeemable Cumulative Preference shares will not be listed with the Exchange and the issue of 8% Redeemable Cumulative... Board Meeting on April 27, 2016
Fredun Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on April 27, 2016, to consider and approve the matter of issuing Redeemable Preference shares and to hold an Extra Ordinary General Meeting in this respect. The Redeemable Preference shares may not be listed subject to all the Regulations and The Companies Act, 2013. Shareholding for the Period Ended March 31, 2016
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here Fixes Book Closure for Interim Dividend
Fredun Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from April 13, 2016 to April 15, 2016 (both days inclusive) for the purpose of Payment of Interim Dividend.